Logo
DCA

Repligen Corporation

RGENHealthcareMedical Instruments & Supplies
121,73 $US
+0.50%
Letzter Preis
121,73 $US
2026-06-03
24h Änderung
+0.50%
0.60 USD
Volumen
650.590
Gehandelte Anteile
Datenzuverlässigkeit
Hoch
10102 Punkte (40 Jahre)

Kursentwicklung

Starten Sie eine Simulation mit diesem Asset

RGEN

Globale Parameter

Verfügbare Daten von 29.4.1986 bis 3.6.2026

Fundamentalanalyse

New
CAGR (5y)
-2.70%
Revenue Growth
Net Margin
6.62%
Profitability
ROE
2.32%
Return on Equity
Debt / EBITDA
3.81
Solvency
PEG Ratio
1.63
Valuation vs Growth
Rev. Growth (TTM)
14.80%
Current Trend

KGV-Historie (5 Jahre)

Historical PE
Average (135.9x)
Current: 114.5x
Technischer Fokus
RGEN
30d-Volatilität
74.92%
Abstand zur MA50
2.86%
Abstand zur MA200
-11.64%
Abstand zum ATH
-62.45%
Momentum 3M
-2.64%
Risiko-Score
N/A

Moderate Volatilität. Momentum neutral.

Über Repligen Corporation

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

In diesen Wert investieren
Kaufen bei Saxo Bank
🏦Regulierter Broker
🌍Globaler Marktzugang
📈Profi-Tools

Werbelink. Kapital unterliegt Risiken.

Technische Analyse & Risiko

Schlüsselkennzahlen

CAGR6.12%
Volatilität74.92%
Max Drawdown-50.64%

Momentum : RGEN

Indicateur synthétique
PEURNEUTREAVIDITÉ
41
Fear

Risikoanalyse

VaR (95%)-6.45%
DCA Gesundheit
60/100

Jüngste Geschichte (60 Tage)

DatumSchlusskursVolumen
2026-06-03121,73 $US650.590
2026-06-02121,13 $US737.914
2026-06-01123,10 $US654.931
2026-05-29123,95 $US823.724
2026-05-28122,73 $US1.425.481
2026-05-27113,17 $US1.125.500
2026-05-26115,19 $US787.000
2026-05-22115,06 $US714.436
2026-05-21113,37 $US990.913
2026-05-20111,74 $US1.164.132
2026-05-19108,52 $US2.199.779
2026-05-18104,20 $US1.547.665
2026-05-15102,87 $US2.307.248
2026-05-14103,38 $US2.010.732
2026-05-13107,03 $US1.660.291
2026-05-12113,60 $US1.454.864
2026-05-11115,91 $US1.283.636
2026-05-08123,46 $US924.244
2026-05-07126,43 $US935.806
2026-05-06125,76 $US1.625.385
2026-05-05125,61 $US2.065.504
2026-05-04118,21 $US1.280.562
2026-05-01117,20 $US751.851
2026-04-30118,31 $US1.609.810
2026-04-29113,11 $US852.039
2026-04-28117,43 $US726.060
2026-04-27118,29 $US779.099
2026-04-24117,60 $US1.234.335
2026-04-23114,06 $US2.165.393
2026-04-22124,40 $US1.016.244
2026-04-21132,70 $US1.086.726
2026-04-20131,99 $US675.203
2026-04-17131,21 $US1.122.130
2026-04-16127,09 $US620.933
2026-04-15131,93 $US810.918
2026-04-14131,03 $US1.184.340
2026-04-13122,59 $US745.757
2026-04-10120,10 $US532.309
2026-04-09119,78 $US587.844
2026-04-08119,77 $US730.218
2026-04-07115,29 $US633.397
2026-04-06116,95 $US557.545
2026-04-02117,78 $US784.691
2026-04-01118,32 $US1.103.774
2026-03-31117,82 $US1.284.049
2026-03-30111,49 $US625.944
2026-03-27110,12 $US797.926
2026-03-26114,42 $US710.452
2026-03-25114,32 $US1.265.751
2026-03-24116,30 $US403.004
2026-03-23116,35 $US808.050
2026-03-20113,88 $US859.375
2026-03-19117,61 $US606.542
2026-03-18117,59 $US801.234
2026-03-17119,27 $US1.250.399
2026-03-16115,11 $US828.563
2026-03-13114,20 $US1.099.079
2026-03-12113,76 $US1.366.590
2026-03-11119,23 $US1.086.288
2026-03-10121,79 $US1.155.900

Verwandte Assets